Comments on the article 'Industry opposes genomic legislation,' published in the 2002 issue of the periodical 'Nature Biotechnology.' Failure of the periodical Ken Chahine's corporate title of vice president of business development and intellectual property for Avigen Inc.; Patent protections afforded to the biotechnology industry.